Cancer Research
Natural compound may enhance chemotherapy for aggressive leukemia
An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya
Researchers linked to the University of Surrey report that forskolin, a plant-derived compound, can slow the growth of KMT2A‑rearranged acute myeloid leukaemia cells in the lab and increase their sensitivity to the chemotherapy drug daunorubicin. The findings, from a study published in the British Journal of Pharmacology, suggest a possible way to make existing treatments more effective, though further research is required before any change to clinical practice.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg have created an AI-powered tool named MAGIC to identify cells with early chromosomal abnormalities linked to cancer. This system automates the detection of micronuclei, small DNA-containing structures that signal potential cancer development. The technology verifies a theory proposed over a century ago by Theodor Boveri.
An Ruwaito ta hanyar AI
Researchers at the University of Waterloo have developed engineered bacteria designed to invade and eat solid tumors from the inside out. The approach uses microbes that thrive in oxygen-free environments, targeting the low-oxygen cores of tumors. A genetic modification allows the bacteria to survive near oxygenated edges, controlled by a quorum-sensing mechanism.
Researchers at Queen Mary University of London have found that rapalink-1, an experimental TOR inhibitor being investigated for cancer therapy, extends the lifespan of fission yeast. The study also uncovered a role for agmatinases in regulating the TOR pathway through a metabolic feedback loop, suggesting potential links between diet, gut microbes, and aging.
An Ruwaito ta hanyar AI
The Bombay High Court has directed an expert committee to review a plea by Datar Cancer Genetics for approving phase 1 human trials of its cancer immunotherapy drug, Per-C-Vax. The court aims for a report within three months amid disputes over regulatory requirements. The hearing was postponed to March 2, 2026.
The Minnesota Wild will host Hockey Fights Cancer Awareness Night on November 16, 2025, during their game against the Vegas Golden Knights. The event, presented by HealthPartners Cancer Care, will feature cancer patients, survivors, and charities, with fans encouraged to wear lavender in support. Various in-game activities and auctions aim to raise funds for cancer research.
An Ruwaito ta hanyar AI An Binciki Gaskiya
An international team has identified an early 'Big Bang' moment in colorectal (bowel) cancer when tumor cells first evade immune surveillance, a finding that could refine who benefits from immunotherapy. The work, funded by Cancer Research UK and the Wellcome Trust, analyzed samples from 29 patients and was published in Nature Genetics on November 5, 2025.
Neutrophils reprogrammed by tumors to produce cancer-promoting CCL3
December 27, 2025 07:13Researchers decode rare cancer-fighting plant compound
December 24, 2025 19:15Researchers develop nanodots to kill cancer cells selectively
December 21, 2025 05:00Spanish researchers develop open-source tool for cancer gene networks
December 11, 2025 19:35Gene-edited CAR-T cells show promise against aggressive T-cell leukemia
November 24, 2025 21:29Scientists map proteins that let carcinomas change identity
November 20, 2025 05:30Blocking FSP1 triggers ferroptosis, curbing lung tumors in mice
November 18, 2025 13:09Amazonian scorpion venom peptide shows paclitaxel-like action against breast cancer cells in lab tests
November 17, 2025 04:20ASU-led study finds cancer marker SerpinB3 also drives wound healing
November 13, 2025 09:30Researchers design smart drug targeting RNA in cancer cells